Antioxidant nanozymes for prevention of diseased kidney from failure.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 36272752.
- Also identified by DOI 10.1016/j.kint.2022.08.003.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Oxidative stress is a state of excessive free radicals and is commonly found with diseased kidneys. Therefore, development of antioxidant-based therapy has been of great interest to biomedical scientists for kidney disease management. One of the drawbacks of using natural antioxidants is their low bioavailability, which limits their anti-free radical efficacy. This commentary discusses novel antioxidant gold-platinum nanoparticles and their potential for prevention of kidney failure in patients who are diagnosed with chronic kidney disease.
Medical subject headings
- Antioxidants
- Metal Nanoparticles